Ampullary neoplastic lesions (ANLs) represent a rare cancer, accounting for about 0.6–0.8%
of all gastrointestinal malignancies, and about 6–17% of periampullary tumors. They can be …

Objectives Endoscopic papillectomy (EP) is a minimally invasive therapy for the
management of ampullary adenomas (AA). We conducted this multicenter study to assess …

Background Endoscopic papillectomy (EP) is an effective method to remove an ampulla of
Vater (AoV) adenoma with minimal invasiveness. We reviewed the clinical outcomes and …

From May 2021 to March 2023, 24 patients (12 male/12 female, 54.5±12.4 years) with 24
gastric submucosal tumors (G-SMTs) underwent snare-assisted endoscopic resection (ER) …

Background Familial adenomatous polyposis (FAP) predisposes individuals to duodenal
adenomas. This study describes the histopathological features of endoscopic and surgical …

We read with great interest the article by Vu Trung et al.[1] analyzing the efficacy and safety
of endoscopic papillectomy for ampullary lesions in patients with familial adenomatous …

Discussion Ampullary adenomas are successfully treated by minimally invasive resection in
over 95% of cases. The risk of pancreatitis can be mitigated by placing pancreatic stents …

We thank Wang et al. for their thoughtful comments and thorough reading of our manuscript
analyzing endoscopic papillectomy for patients with familial adenomatous polyposis (FAP) …

Ampullary adenomas can develop sporadically or in association with genetic syndromes,
most frequently familial adenomatous polyposis (FAP), an autosomal dominant disease …